Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions

F. O. Ergur, G. Ulubay, N. Bayraktar (Ankara, Turkey)

Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Session: Novel approach in diagnosis and treatment of pleural effusions
Session type: E-Communication Session
Number: 228

Congress or journal article abstractE-poster

Abstract

Pleural fluids(PF) develop due to several reasons. Nowadays, Light criteria‘s are used to differentiate transudative and exudative pleural effusions. However, Light criteria‘s could fail in some situations.
This study was performed to research the role of the PF and serum NT-proBNP levels in differential diagnosis of pleural effusions.
Ninety-one patients with pleural effusion were included in this study. 23 patients with PF secondary to heart failure(Group 1), 25 patients with noncardiac transudative PF (Group 2) and 43 patients with exudative PFdue to other problems(Group 3). PF NT-proBNP and serum NT-proBNP levels were performed in all patients as well as Light‘s criteria‘s. PF and serum NT-proBNP levels were increased(p< 0,001) in Group 1 patients. Significant correlation was found between serum and blood NT-proBNP levels(p< 0,05). Serum NT-proBNP and PF NT-proBNP levels were increased in Group 2(p< 0,001).
Our study demonstrated that both of serum and PF NT-proBNP assays could differentiate cardiac PF. We suggest that serum NT-proBNP assay could be more preferable to thorasynthesis in patients who are suggesting heart failure clinically. Moreover, serum and PF NT-proBNP assays could play an important role in differential diagnosis of exudative PF secondary to renal failure which have exudative PF according to Light criteria‘s.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. O. Ergur, G. Ulubay, N. Bayraktar (Ankara, Turkey). Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions. Eur Respir J 2010; 36: Suppl. 54, 228

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010

Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009

Comparison and relationship of cholesterol and lipoproteins of pleural effusions with serum levels of them in exudative and transudative pleural fluid
Source: Eur Respir J 2005; 26: Suppl. 49, 446s
Year: 2005

Diagnostic value of IL-8 in differentiating between exudative and transudative pleural effusion
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008

Role of C-reactive protein in distinguishing between transudative and exudative pleural effusion
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019


Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009


Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003

Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012


Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion
Source: Annual Congress 2008 - Pleural effusion
Year: 2008

Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019

Pleural fluid leptin level for the differential diagnosis of pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006

The diagnostic value of pleural fluid C-reactive protein level in pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Angiopoietin-2 levels are elevated in exudative pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005

Diagnostic value of serum - effusion albumin gradient in distinguishing exudative and transudative effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 442s
Year: 2002

Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020


Utility of pleural fluid glucose measurement in TB pleural effusions.
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


Role of serum and pleural fluid NT-proBNP levels in identifying pleural effusion due to heart failure
Source: Annual Congress 2008 - Pleural effusion
Year: 2008


Prognostic features of residual pleural thickening after parapneumonic pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 605s
Year: 2002

Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017